Targeron Applications

Novel Approaches in Oncology and Virology

Both cancer and viral infections cause significant individual and global economic devastation

Novel approaches are needed for the treatment of various malignancies.  Despite recent limited success in cancer immuno-therapeutics, treatments tend to be marginally effective and often accompanied by significant side effects reflecting the challenges of empowering the immune system to find and eliminate tumor cells throughout the body with a minimal collateral damage to the patient.  Development of therapies targeting numerous cell types is required because tumor cells, even within a given cancer, are heterogeneous, and there is a broad variety of immune and non-immune cells (stromal, endothelial cells) that affect tumor growth.

Treatment of viral infections presents a major clinical challenge due to:

  • The existence of numerous globally-spread chronic viral infections.
  • Constant emergence and re-emergence of diverse highly pathogenic viruses.
  • The lack of broad-spectrum antivirals.
  • Development of direct acting antivirals (DAA) or vaccines is time-consuming, they are virus-specific, and their efficacies prone to be overcome by emergence of virus variants resistant to DAAs or vaccines.

Animal models demonstrate that our technology is effective against both cancer and viral infections

Targeron’s initial focus is on advancing our technology in immuno-oncology, specifically for the treatment of advanced metastatic Triple Negative Breast Cancer (TNBC), where there is a significant unmet need. Targeron also explores the use of our proprietary biologics for the treatment of respiratory infections with a specific focus on prophylactics for influenza and other respiratory viral diseases.

About Targeron Therapeutics

Technology

Team

Background image of pen and text

Publications

Learn about Targeron’s novel patented technology with broad-spectrum applications.

Contact us with inquiries or to schedule an introductory call.

contact

Scroll to Top
Skip to content